Ryan Marissa, Zapata Evelyn Handel, Weru Irene, Cracknell Annette Netty V
Pharmacy Department, Princess Alexandra Hospital, Brisbane, Australia.
Centre for Online Health, The University of Queensland, Brisbane, Australia.
J Oncol Pharm Pract. 2025 Oct;31(7):1104-1114. doi: 10.1177/10781552251332199. Epub 2025 Apr 23.
IntroductionThe International Society of Oncology Pharmacy Practitioners (ISOPP) has over 3500 members across 110 countries. ISOPP's strategic objectives are membership engagement, empowering the global oncology pharmacy community, facilitating professional development, and advocating for advancement. Aligning with these objectives, this research aimed to describe global oncology pharmacy service provision and knowledge requirements.MethodsFifty-three ISOPP global oncology pharmacy leaders from 45 countries were invited to complete a survey. Questions in the survey explored whether protected titles existed for oncology practitioners, the oncology pharmacy service levels that were being offered from the seven levels proposed, knowledge requirements for these levels, and access to education. Free text comments were analyzed for context or themes and described descriptively. Based on responses, the proposed service levels and required knowledge were reviewed to establish the ISOPP Oncology Pharmacy Service Levels.ResultsResponses from 35 countries were received. Thirty-five (100%) participants reported that pharmacist was a protected title, and 18 (51%) participants reported that pharmacy technician was protected. However, oncology pharmacist was a protected title in one (3%) country only, Singapore. Fourteen (40%) countries delivered all seven levels, and 35 (100%) countries delivered at least three levels. Some participants reported being unfamiliar with some of the survey terminology; this information was used to clarify the wording of the service levels and knowledge requirements.ConclusionThis global review of oncology pharmacy services will aid professional development and advancement, by connecting countries with mentoring opportunities and resources, and establishing a benchmark for the future growth of services globally.
引言
国际肿瘤药学从业者协会(ISOPP)在110个国家拥有超过3500名会员。ISOPP的战略目标是会员参与、赋能全球肿瘤药学界、促进专业发展以及倡导进步。为实现这些目标,本研究旨在描述全球肿瘤药学服务的提供情况和知识要求。
方法
邀请了来自45个国家的53位ISOPP全球肿瘤药学领导者完成一项调查。调查中的问题探讨了肿瘤学从业者是否有受保护的头衔、从提议的七个级别中提供的肿瘤药学服务水平、这些级别的知识要求以及教育机会。对自由文本评论进行上下文或主题分析,并进行描述性描述。根据回复,对提议的服务水平和所需知识进行审查,以确定ISOPP肿瘤药学服务水平。
结果
收到了来自35个国家的回复。35名(100%)参与者报告称药剂师是一个受保护的头衔,18名(51%)参与者报告称药房技术员是受保护的。然而,只有一个国家(3%),即新加坡,肿瘤药师是一个受保护的头衔。14个(40%)国家提供了所有七个级别,35个(100%)国家至少提供了三个级别。一些参与者报告说不熟悉某些调查术语;这些信息被用于澄清服务水平和知识要求的措辞。
结论
这项对全球肿瘤药学服务的综述将有助于专业发展和进步,通过将各国与指导机会和资源联系起来,并为全球服务的未来增长建立一个基准。